All News
Smartphone T2T management of RA & SLE is possible. With over 127,316 DAS28 & 42,593 SLEDAI assessments over 2 yrs. T2T was lowest in spring for both, correlating w/ holidays in China. #ACR20 Abstr#1018 https://t.co/bGJtSTDqzo https://t.co/34za6kokOp
Dr. John Cush RheumNow ( View Tweet)
High #bloodpressure, jaw claudication and temporal artery abnormalities on palpation associated with increased risk of serious ischaemic events in #GCA, incl visual loss and #CVA. #MSK symptoms including PMR are protective.
Abs#1944 #ACR20 @RheumNow
https://t.co/sTeql8py9r
Mrinalini Dey DrMiniDey ( View Tweet)
@psufka @wendycostello2 @RheumNow I love seeing patients in person! However, being pregnant during COVID19 made me adjust my practice significantly (as we all did.) Watch https://t.co/99R5rPryui it helped me to visualize the PE in an entirely new way. @RheumNow
Dr. Rachel Tate uptoTate ( View Tweet)
Abs#1562 Detected subclinical synovitis/tenosynovitis in 37.2% of PsA pts in clinical remission. Do you routinely use MRI to monitor disease activity in your PsA patients? @RheumNow #ACR20
Robert B Chao, MD doctorRBC ( View Tweet)
SELECT-CHOICE on UPA vs ABA in RA in NEJM Oct 2020. How about PROs? UPA wins in phys fxn, pain, general health over ABA. Abst#1728 @RheumNow #ACR20. ABA better if a safety concern, but this is more evid to go for UPA
Eric Dein ejdein1 ( View Tweet)
Very young rheum patients (<21 y.o) may have higher risk for preterm delivery compared to those 21-25 y.o
Abstr#1762 #ACR20 @rheumnow
https://t.co/NyLEan2sA1
k dao KDAO2011 ( View Tweet)
Do you take into account the location of bone marrow edema in the SI joint of a pt w/ inflammatory back pain when trying to determine if a pt has SpA? Check out Abst1535 at #ACR20 for more thoughts on this. @RheumNow @ElaineHusniMD
Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)
Dr. Petri et al: Very ⬇ 25(OH)Vit D levels (<20ng/mL) is associated w/ renal insufficiency in SLE
🚨Levels >60ng/mL can ⬆renal insufficiency
This reinforces benefits of Vit.D supplementation (⬇ protnuria; immunomodulation)
@RheumNow #ACR20 abs1789 https://t.co/BJciK77fcp
sheila RHEUMarampa ( View Tweet)
SLR of frequency of visual ischaemia (VI) in relapse & follow-up of GCA
-VI >4weeks after GCA diagnosis is uncommon
-VI occurs in up to 3% patients with at least one relapse
-VI reported 3.5x more in RCTs vs retrospective studies
Abs#1929 #ACR20 @RheumNow
https://t.co/OztFRZ9VHc
Mrinalini Dey DrMiniDey ( View Tweet)
#mskus findings in pt w/normal muscle volume(ABC) vs. w/sarcopenia(DEF).
This Japanese study showed US of VL muscle is useful in discriminating RA pts w & w/o sarcopenia. @RheumNow #ACR20 abs1537 https://t.co/Gv7V0eebEt
sheila RHEUMarampa ( View Tweet)
@rheumnow #acr20 #absL03 RCDB PC ph2 trial TYK2i Deucravacitinib for PsA: ACR 20 at 16wk 6 mg 52.9% & 12 mg 62.7% vs PBO 31.8%. csDMARD & TNFi failure included. no serious infections, herpes zoster, opportunistic infections, or thrombotic events https://t.co/WVm4llPv5i
Olga Petryna DrPetryna ( View Tweet)
Abst#1720: Interesting results in predicting +CCP progression to IA: high BMI ⬆️ risk, EtOH ⬇️ risk, Cigarettes no effect but low smoking group. #ACR20 @RheumNow.
Eric Dein ejdein1 ( View Tweet)
@rheumNow #ACR20 #ABSL02 registry data: Pts on biologics more likely to Shield at Home during COVID 19 as opposed to non-biologic or no systemic Rx at all. Such stringent mitigation tactics may contribute to the reported lower risk of adverse COVID-19 outcomes in biologics Pts
Olga Petryna DrPetryna ( View Tweet)
Listen to part I of our #ACR20 Day 3 recap. Follow the link below or find us on Apple podcasts.
https://t.co/STTgimaUjp https://t.co/Zh2wZRnbyS
Links:
Dr. John Cush RheumNow ( View Tweet)
Retrosp study in France compared MRIs of 96 pts w/ SpA (65% w/ IBP) vs 104 w/o (25% w/ IBP):
- 65% of pts w/ SpA had bone marrow edema (BME) mainly in the iliac quad of intermed middle segment
- 20% w/o SpA had BME mainly in antero-middle quad. #Abst1535 #ACR2020 @RheumNow https://t.co/1ptGGUbUS4
Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)
~1/3 early RA patients report unacceptable pain w/in one year of diagnosis. 69% have pain w/ low inflammation. No objective baseline measures predict unacceptable pain. #ACR20 @RheumNow Abs#1716 We need to start pain approaches at time of diagnosis for all
Eric Dein ejdein1 ( View Tweet)
#AerobicExercise improves #Fatigue & #QualityofLife in women w/ #SLE
- ↓Fatigue & ↑overall health after exercise program
- No increase in #lupus activity
- Data may inform understanding of fatigue & exercise interventions in SLE
Abs#1838 #ACR20 @RheumNow
https://t.co/0YtYHrWp6t
Mrinalini Dey DrMiniDey ( View Tweet)
How often do you perform NFC in suspected SSc patients? @RheumNow #ACR20
sheila RHEUMarampa ( View Tweet)
@uptoTate @RheumNow It is only when I started working more closely with our rheum team to look at improving services did I realise how high no-shows are ! We have a 2yr waiting list so these appts are like gold dust. Unfortunately telemedicine not a viable option for your 1st rheum appt.
Wendy Costello wendycostello2 ( View Tweet)
Pulmonary disease and glucocorticoid usage risk factors for RA medication changes in first 3 month of #COVID19. Pts with higher reported disease activity more likely to make Rx changes #ACR20 @RheumNow. Abst#L05.
Eric Dein ejdein1 ( View Tweet)